Sana Biotechnology IncSANA
Price$2.89

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 30 Jun 2026
Net Income -$211.8MTTM through 30 Jun 2026
Free Cash Flow -$135.1MTTM through 30 Jun 2026

Margins

Current

Returns

-39.6%ROE
-12.6%ROA

Balance Sheet Health

Debt / Equity0.69x
Current Ratio1.29x
Net Debt-$25.8Mnet cash position
Cash & Equivalents$57.1M

Quality Metrics

Altman Z-Score-5.74
Piotroski F-Score3 / 9
Earnings-Beat Rate75.0%

Multi-Year Trend

Diluted EPS-$0.75TTM
'20'21'22'23'24'25
FY2025: $-0.96

Dividend

No dividend

Capital Allocation

R&D Spend$124.5M

Segment Performance

SegmentRevenueYoYOutlook
Research and Development$0
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.